Human cryptococcosis: Relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas

Mycopathologia

Volumn 159, Issue 1, 2005, Pages 7-11

  Delgado, A C N ^a   Taguchi, H ^b   Mikami, Y ^b   Myiajy, M ^b   Villares, M C B ^a   Moretti, M L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Acquired immuno deficiency syndrome; Antifungal susceptibility testing; Cryptococcus neoformans; Molecular typing; Pigeon droppings

Indexed keywords

ANTIFUNGAL AGENT; FUNGAL DNA;

ANIMAL; BRAZIL; CHEMISTRY; CONFERENCE PAPER; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KARYOTYPING; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PIGEONS AND DOVES; PULSED FIELD GEL ELECTROPHORESIS; RURAL POPULATION; URBAN POPULATION;

ANIMALS; ANTIFUNGAL AGENTS; BRAZIL; COLUMBIDAE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DNA, FUNGAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; KARYOTYPING; MICROBIAL SENSITIVITY TESTS; RURAL POPULATION; URBAN POPULATION;

COLUMBA; CRYPTOCOCCUS NEOFORMANS VAR. NEOFORMANS; FILOBASIDIELLA NEOFORMANS;

EID: 17744371938     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-004-9618-4     Document Type: Conference Paper

References (22)

1. BP Currie A Casadevall 1994 Estimation of the prevalence of cryptococcal infection among HIV infected individuals in New York City. Clin Infect Dis 19 1029 1033
2. Ministério da Saúde. Programa nacional de doenças sexualmente transmissíveis Brasília, Brasil. Boletim Epidemiológico de AIDS 1999; Ano I (01): 44.
3. R Rozembaum AJR Gonçalves 1994 Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 18 369 380
4. TG Mitchell JR Perfect 1995 Cryptococosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8 515 548
5. A Casadevall JR Perfect 1998 Cryptococcus neoformans A Casadevall JR Perfect Ecology of Cryptococcus neoformans ASM Press Washington DC 41 70
6. MS Lazéra FDA Pires LC Coura MM Nishikawa 1996 Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 34 127 131
7. SM Levitz 1991 The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13 1163 1169
8. BP Currie LF Freundlich A Casadevall 1994 Restriction fragment length polymorphism analyses of Cryptococcus neoformans strains from environmental (pigeon excreta) and clinical strains in New York City. J Clin Microbiol 32 1188 1192
9. SP Franzot JS Hamdan BP Currie A Casadevall 1997 Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: Evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol 35 2243 2251
10. Y Yamamoto S Kohno H Koga H Kakeya K Tomono M Kaku T Yamazaki M Arisawa K Hara 1995 Random amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki. J Clin Microbiol 33 3328 3332
11. SH Alves LT Oliveira JM Costa I Lubeck AK Casali MH Vainstein 2001 In vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in southern of Brazil. Rev Inst Med Trop São Paulo 43 267 270
12. F Barchiese R Hollis SA Messer G Scalise MG Rinald MA Pfaller 1995 Electrophoretic and in vitro antifungal susceptibility of Cryptococcus neoformans strains from AIDS patients. Diagn Microbiol Infect Dis 23 99 103
13. AJ Bava R Negroni 1989 Susceptibilidade "in vitro" de cepas de Cryptococcus a 5 drogas antifúngicas. Rev Inst Med Trop São Paulo 31 346 350
14. BM Calvo AL Colombo O Fischiman A Santiago L Thompson M Lazera F Telles K Fukushima K Nishimura R Tanaka M Myiajy ML Moretti-Branchini 2001 Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical strains of Cryptococcus neoformans from Brazil, Chile, and Venezuela. J Clin Microbiol 39 2348 2350
15. SP Franzot JS Hamdan 1996 In vitro susceptibilities of clinical and environmental strains of Cryptococcus neoformans to five antifungal drugs. Antimicrobiol Agent Chemother 40 822 824
16. RA Fromtling GK Abruzzo A Ruiz 1989 Virulence and antifungal susceptibility of environmental and clinical strains of Cryptococcus neoformans from Puerto Rico. Mycopathologia 106 163 166
17. A Li K Nishimura R Tanaka S Wu M Miyaji 1993 The isolation of Cryptococcus neoformans from pigeon droppings and naturally and clinically sourced isolates in China. Mycopathologia 124 1 5
18. Lacaz CS, Porto E, Martins JEC. Técnicas micológicas e imunológicas. In Micologia médica. Fungos, actinomicetos e algas de interesse médico. São Paulo, Brazil: Sarvier, 1991: 545-608.
19. KJ Kwon-Chung I Polacheck JE Bennett 1982 Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 15 535 537
20. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: document M27A. Villanova PA. Documente M27A, 1997.
21. BC Fries F Chen BP Currie A Casadevall 1996 Karyotype instability in Cryptococcus neoformans infection. J Clin Microbiol 34 1531 1534
22. BI Wickes TDE Moore KJ Kwon-Chung 1994 Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology 140 543 550